
Lonafarnib is a farnesyltransferase inhibitor (FTI) that is being investigated in a human clinical trial as a potential treatment for progeria. Lonafarnib is a synthetic tricyclic derivative of carboxamide with antineoplastic properties. As such, it is used primarily for cancer treatment. For those with progeria, research has shown that the drug r...
Found on
http://en.wikipedia.org/wiki/Lonafarnib

An anticancer drug that belongs to the family of drugs called enzyme inhibitors. Also called SCH 66336.
Found on
http://www.cancer.gov/dictionary?expand=L
No exact match found.